◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
K Pharma,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023
+Revenue -- 1.0B
Revenue Growth % -- --
+Operating Income -836.3M 366.1M
Operating Margin % -- 36.6%
Non Operating Income 1.3M 66,000
Non Operating Expenses 1.2M 21.9M
Ordinary Income -836.2M 344.2M
Income Before Taxes -844.1M 301.1M
Income Taxes 2.4M 40.7M
+Net Income -846.5M 260.3M
Net Margin % -- 26.0%
Eps -72.94 25.42
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023
Cash And Deposits 2.3B 3.3B
Current Assets 2.3B 3.3B
Noncurrent Assets 4.9M 4.9M
Total Assets 2.4B 3.3B
Current Liabilities 63.5M 178.5M
Total Liabilities 94.8M 209.1M
Retained Earnings -846.5M -752.7M
Total Equity 2.3B 3.1B
Equity Ratio 0.96 0.94
Book Value Per Share 194.60 267.55
Num Employees 17.00 15.00
Roe -- 0.12
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023
Operating Cash Flow -983.7M 454.4M
Investing Cash Flow -14.5M -11.1M
Financing Cash Flow -- 1.5B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...